Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2V617F mutational status

被引：7
|
作者：
Ohyashiki, K. [1 ]
Akahane, D.
Gotoh, A.
Ito, Y.
Tauchi, T.
Miyazawa, K.
Kimura, Y.
Ohyashiki, J. H.
机构：
[1] Tokyo Med Univ, Dept Internal Med 1, Div Hematol, Tokyo, Japan
[2] Tokyo Med Univ, Intractable Immune Syst Dis Res Ctr, Tokyo, Japan
来源：
LEUKEMIA | 2007年 / 21卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2404829
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2544 / 2545
页数：3
相关论文
共 50 条
  • [21] The JAK2V617F mutation and thrombosis
    Austin, S. K.
    Lambert, J. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (03) : 307 - 320
  • [22] JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
    Guglielmelli, Paola
    Loscocco, Giuseppe G.
    Mannarelli, Carmela
    Rossi, Elena
    Mannelli, Francesco
    Ramundo, Francesco
    Coltro, Giacomo
    Betti, Silvia
    Maccari, Chiara
    Ceglie, Sara
    Chiusolo, Patrizia
    Paoli, Chiara
    Barbui, Tiziano
    Tefferi, Ayalew
    De Stefano, Valerio
    Vannucchi, Alessandro M.
    BLOOD CANCER JOURNAL, 2021, 11 (12)
  • [23] JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia
    Maria Luigia Randi
    Elisabetta Ruzzon
    Fabiana Tezza
    Margherita Scapin
    Elena Duner
    Raffaella Scandellari
    Fabrizio Fabris
    Aging Clinical and Experimental Research, 2011, 23 : 17 - 21
  • [24] Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
    A Tefferi
    J J Strand
    T L Lasho
    R A Knudson
    C M Finke
    N Gangat
    A Pardanani
    C A Hanson
    R P Ketterling
    Leukemia, 2007, 21 : 2074 - 2075
  • [25] Influence of JAK2V617F Allele Burden on Hematological Response in the Treatment of Polycythemia Vera
    Shikhbabaeva, Dzhariyat
    Shuvaev, Vasily
    Golovchenko, Regina
    Udaleva, Vera
    Fominykh, Mikhail
    Zotova, Irina I.
    Polushkina, Lyubov
    Martynkevich, Irina
    Abdulkadyrov, Kudrat
    BLOOD, 2016, 128 (22)
  • [26] Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status
    Finazzi, Guido
    Rambaldi, Alessandro
    Guerini, Vittoria
    Carobbo, Alessandra
    Barbui, Tiziano
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 135 - 136
  • [27] Dynamic Increase in JAK2V617F Allele Burden Is a Predictive Parameter for the Transformation into Myelofibrosis from Polycythemia Vera and Essential Thrombocytosis
    Shirane, Shuichi
    Araki, Marito
    Morishita, Soji
    Hironaka, Yumi
    Noguchi, Masaaki
    Koike, Michiaki
    Hirano, Takao
    Ohsaka, Akimichi
    Komatsu, Norio
    BLOOD, 2014, 124 (21)
  • [28] Detection of JAK2V617F used for diagnosis of polycythemia vera and correlation with other biomarkers
    Daniels, L.
    Vermeulen, K.
    Van De Velde, A. L.
    Vrelust, I.
    Gadisseur, A. P.
    Schroyens, W.
    Berneman, Z. N.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 262 - 262
  • [29] FREQUENCY OF MUTATIONS IN THE GENE FOR HEAT IN PATIENTS WITH POLYCYTHEMIA VERA JAK2V617F NEGATIVE
    Xandri, M.
    Zamora, L.
    Cabezon, M.
    Velez, P.
    Marce, S.
    Boque, C.
    Xicoy, B.
    Fernandez, C.
    Dominguez, D.
    Gallardo, D.
    Granada, I
    Ruiz-Xiville, N.
    Cisneros, A.
    Grau, J.
    Campos, D.
    Santafe, E.
    Villena, C.
    Ribera, J. Ma
    Milla, F.
    Feliu, E.
    HAEMATOLOGICA, 2015, 100 : 79 - 79
  • [30] Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera
    Ganly, Peter
    Hanrahan, Vickie
    Baker, Bart
    Romeril, Ken
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) : 80 - 82
12345